The clinical dementia rating scale could be helpful in differentiating frontotemporal dementia from Alzheimer's disease
β Scribed by Tor Atle Rosness; Per Kristian Haugen; Knut Engedal
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 57 KB
- Volume
- 26
- Category
- Article
- ISSN
- 0885-6230
- DOI
- 10.1002/gps.2555
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Background Despite striking neuropsychological and behavioural differences between Alzheimer's disease (AD) and frontotemporal dementia (FTD), clinical diagnostic criteria failed to discriminate FTD from AD patients. We therefore developed the Middelheim Frontality Score (MFS), a disease-long clinic
however because of non-specific symptoms of some diseases in geriatric patients, no clear incidence was registered. In conclusion, in the present study, in nearly half of the off-label use of drugs, geriatric residents were not aware of this unapproved use. The off-label use of drugs was justified
## Objective: Since patients with dementia with lewy bodies (dlb) tend to have greater impairment of attention and construction and better memory ability on neuropsychological tests than patients with alzheimer's disease (ad), we determined if the items that measure attention, memory, and construct
## Abstract ## Background The Alzheimer's Disease Assessment Scale (ADAS) is often used in international multicenter trials. Use across countries presupposes correct translation and adaptation of the scale, and maintenance of its psychometric properties. ## Objectives To compare the various tran